TC
GILD icon

TFS Capital’s Gilead Sciences GILD Stock Holding History

TFS Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,539
Closed -$463K – 141
2017
Q2 		$463K Sell
6,539
-252
-4% -$16.8K 0.18% 185
2017
Q1 		$461K Buy
6,791
+97
+1% +$6.82K 0.15% 246
2016
Q4 		$479K Buy
6,694
+1,836
+38% +$136K 0.13% 254
2016
Q3 		$384K Buy
+4,858
New +$395K 0.09% 354

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TFS Capital's GILD Position: Q3 2017 in Review

TFS Capital sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 6,539 shares — an estimated $463K sold.

TFS Capital first reported a position in GILD in Q3 2016 and held it in 4 quarters. The position peaked at $479K in Q4 2016. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • TFS Capital reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 6,539 Gilead Sciences shares in Q3 2017, an estimated $463K.
  • TFS Capital first reported a position in Gilead Sciences in Q3 2016 and held it in 4 quarters.
  • TFS Capital's Gilead Sciences position peaked at $479K in Q4 2016.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.